Large-scale testing (Phase 3)Study completedNCT00002967What this trial is testingOctreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast CancerWho this might be right forBreast Cancer NSABP Foundation Inc
Not applicableStudy completedNCT05695859What this trial is testing99mTc-DARPinG3 SPECT/CT for Non-invasive HER2-AX in Breast Cancer With Metastatic Lymph Nodes Before Targeted TherapyWho this might be right forBreast Cancer Female Tomsk National Research Medical Center of the Russian Academy of Sciences 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Study completedNCT00154388What this trial is testingPhase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesWho this might be right forLife Threatening Diseases Novartis Pharmaceuticals 185
Testing effectiveness (Phase 2)Active Not RecruitingNCT01334021What this trial is testingGenetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast CancerWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+20 more M.D. Anderson Cancer Center 1,100
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Large-scale testing (Phase 3)Study completedNCT03197935What this trial is testingInvestigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast CancerWho this might be right forTriple-negative Breast Cancer Hoffmann-La Roche 333
Large-scale testing (Phase 3)Looking for participantsNCT06126640What this trial is testingA Phase III, Active-Controlled Study of SHR-A1811 Versus Trastuzumab Emtansine (T-DM1) in HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant TherapyWho this might be right forHER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy Jiangsu HengRui Medicine Co., Ltd. 1,600
Large-scale testing (Phase 3)UnknownNCT01204801What this trial is testingRandomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer TumorsWho this might be right forBreast Cancer Medifocus, Inc. 238
Not applicableActive Not RecruitingNCT03503799What this trial is testingReaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast CancerWho this might be right forPrimary Invasive Breast CancerEstrogen Receptor Positive TumorHuman Epidermal Growth Factor Receptor 2 Negative Tumor North Eastern German Society of Gynaecological Oncology 1,191
Large-scale testing (Phase 3)Study completedNCT00002564What this trial is testingNutrition Intervention in Treating Women With Breast CancerWho this might be right forBreast Cancer Institute for Cancer Prevention (IFCP) 2,500
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT01891357What this trial is testingPhase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast CancerWho this might be right forCarcinoma, Ductal, Breast West German Study Group 64
Testing effectiveness (Phase 2)Ended earlyNCT01230970What this trial is testingExploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast CancerWho this might be right forBreast Cancer Ipsen 2
Early research (Phase 1)Study completedNCT03980509What this trial is testingA "Window Trial" on Curcumin for Invasive Breast Cancer Primary TumorsWho this might be right forBreast Cancer Medical University of South Carolina 22
Early research (Phase 1)Study completedNCT00028496What this trial is testingVaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Ended earlyNCT00148720What this trial is testingCapecitabine in Women With Operable Breast CancerWho this might be right forInvasive Breast CarcinomaPrimary Invasive Breast CancerStage I Breast Cancer+2 more Dana-Farber Cancer Institute 80
Testing effectiveness (Phase 2)Study completedNCT05900986What this trial is testingLS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast CancerWho this might be right forBreast CancerDCISInvasive Duct Carcinoma of Breast Integro Theranostics 22
Not applicableActive Not RecruitingNCT04314401What this trial is testingNational Cancer Institute "Cancer Moonshot Biobank"Who this might be right forAcute Myeloid LeukemiaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+26 more National Cancer Institute (NCI) 1,600
Testing effectiveness (Phase 2)Ended earlyNCT01220128What this trial is testingEvaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast CancerWho this might be right forNeoplasms, Breast GlaxoSmithKline 66